RxSight, Inc.
NASDAQ:RXST
Overview | Financials
Company Name | RxSight, Inc. |
Symbol | RXST |
Currency | USD |
Price | 33.66 |
Market Cap | 1,356,649,470 |
Dividend Yield | 0% |
52-week-range | 33.03 - 66.54 |
Industry | Medical Devices |
Sector | Healthcare |
CEO | Dr. Ronald M. Kurtz M.D. |
Website | https://www.rxsight.com |
An error occurred while fetching data.
About RxSight, Inc.
RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery.
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD